Floatz logo

499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Afp Specific T Cell Receptor T Cells
Hepatocellular Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd.P1CC (43)
Autologous Natural Killer / Natural Killer T Cell Immunotherapy
Hepatocellular Carcinoma
Dr Cipto Mangunkusumo General HospitalP1CC (43)
Bgb-B2033
Hepatocellular Carcinoma
BeOne MedicinesP1CC (43)
Catch T Cells
Hepatocellular Carcinoma
Baylor College of MedicineP1CC (43)
Cobolimab
Hepatocellular Carcinoma
GlaxoSmithKlineP1/2CC (43)
Decoy20
Hepatocellular Carcinoma
Indaptus Therapeutics, IncP1/2CC (43)
Dostarlimab
Hepatocellular Carcinoma
GlaxoSmithKlineP1/2CC (43)
Eribulin
Hepatocellular Carcinoma
GI Innovation, Inc.P1/2CC (43)
et140203 t cells
Hepatocellular Carcinoma
Eureka Therapeutics Inc.P1/2CC (43)
Fludarabine Phosphate For
Hepatocellular Carcinoma
Chinese PLA General HospitalP1/2CC (43)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-31*01 (89.9%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (85.3%)-Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa
Hepatocellular Carcinoma
Cancer Research UKP1/2CC (43)
gi-102
Hepatocellular Carcinoma
GI Innovation, Inc.P1/2CC (43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Hepatocellular Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Hepatocellular Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Ineo-Vac-R01
Hepatocellular Carcinoma
Yinghua XuP1/2CC (43)
Irx 2
Hepatocellular Carcinoma
City of Hope Medical CenterP1CC (43)
Mdn-001
Hepatocellular Carcinoma
Suzhou Mednovo Yi Medical Technology Co., Ltd.P1CC (43)
pf-07263689
Hepatocellular Carcinoma
PfizerP1CC (43)
Pradusinstobart
Hepatocellular Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Pumitamig
Hepatocellular Carcinoma
Bristol-Myers SquibbP1/2CC (43)
ryz801
Hepatocellular Carcinoma
RayzeBio, Inc.P1/2CC (43)
Shr-2524
Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1CC (43)
Trastuzumab Deruxtecan
Hepatocellular Carcinoma
GI Innovation, Inc.P1/2CC (43)
Tucidinostat
Hepatocellular Carcinoma
Great Novel Therapeutics Biotech & Medicals CorporationP1/2CC (43)
Tyra-430
Hepatocellular Carcinoma
Tyra Biosciences, IncP1CC (43)
Vmd-102
Hepatocellular Carcinoma
VM Discovery, Inc.P1/2CC (43)
bay3547922
Hepatocellular Carcinoma
BayerP1CC (42)
bay3630942
Hepatocellular Carcinoma
BayerP1CC (42)
ipm001
Hepatocellular Carcinoma
Peking Union Medical College HospitalP1CC (42)
Γδ T Cells
Hepatocellular Carcinoma
Beijing 302 HospitalP1CC (42)
AK 127
Hepatocellular Carcinoma
AkesoP1/2CC (41)
ak130
Hepatocellular Carcinoma
AkesoP1/2CC (41)
Alintegimod
Hepatocellular Carcinoma
7 Hills Pharma, LLCP1/2CC (41)
Aln-Bcat
Hepatocellular Carcinoma
Alnylam PharmaceuticalsP1CC (41)
Amsulostat
Hepatocellular Carcinoma
University of RochesterP1/2CC (41)
Anti-Gpc3-Car Autologous T Lymphocytes
Hepatocellular Carcinoma
Roswell Park Cancer InstituteP1CC (41)
Anti-Gpc3 Car-T
Hepatocellular Carcinoma
Zhejiang UniversityP1CC (41)
Armored And Gpc3-Targeted Autologous Car T-Cell
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.P1/2CC (41)
Ast-201
Hepatocellular Carcinoma
Aptamer Sciences, Inc.P1CC (41)
au409
Hepatocellular Carcinoma
Lee's Pharmaceutical LimitedP1CC (41)
azd5851
Hepatocellular Carcinoma
AstraZenecaP1/2CC (41)
AZD9793
Hepatocellular Carcinoma
AstraZenecaP1/2CC (41)
b7-h3 car t cells
Hepatocellular Carcinoma
St. Jude Children's Research HospitalP1CC (41)
bi-1910
Hepatocellular Carcinoma
BioInvent International ABP1/2CC (41)
Blu-701
Hepatocellular Carcinoma
Blueprint Medicines CorporationP1CC (41)
Bpi-371153
Hepatocellular Carcinoma
Betta Pharmaceuticals Co., Ltd.P1CC (41)
cd-801
Hepatocellular Carcinoma
Shanghai Changzheng HospitalEarly P1CC (41)
Cdk-004
Hepatocellular Carcinoma
Codiak BioSciencesP1CC (41)
ct011 car-gpc3 t cells
Hepatocellular Carcinoma
CARsgen Therapeutics Co., Ltd.P1CC (41)
ct0181 cells
Hepatocellular Carcinoma
Peking UniversityP1CC (41)
Showing 301 to 350 of 499 assets
PreviousPage 7 of 10Next